Objective To qualitatively assess the barriers and facilitators to uptake of referral services amongst high-risk pregnant women in rural Rajasthan. Methods A purposive sample of pregnant women with high-risk conditions requiring referral follow-up care (severe hypertension, moderate anemia, and severe anemia) were considered for inclusion. In-depth individual interviews were conducted in the local dialect, Mewari. Interviews were transcribed, coded, and organized for thematic generation as per the analytical framework described in the socio-ecological model. Results 19 high risk pregnant women of low socioeconomic backgrounds across 15 villages were interviewed. Barriers to referral care included lack of transportation, household responsibilities, and limited awareness, education, and social support. The most prominent barrier was lack of accompaniment to the referral center by a family member or health worker. Facilitators included available husbands, engaged heath workers, supportive neighbors, and other female family members who shared past experiences. Conclusions Social support at the interpersonal and community level was key to overcoming referral care barriers faced by high-risk pregnant women in rural Rajasthan. Interventions that enhance social support may improve uptake of referral care services by high-risk pregnant women.

Background: In 2017, the pneumococcal conjugate vaccine (PCV) was introduced into the Indian immunization program as a priority. However, monitoring the implementation of this program has been a major challenge in rural India. Novel digital health platforms, used to track vaccine delivery, can address this issue. Methods: We analyzed data collected in a rural part of the Udaipur District of India, which recently introduced PCV13 into the routine immunization program. The data were collected by Khushi Baby, a novel technology platform which facilitates tracking the vaccination status of individual children. We assessed the percent of children receiving 1, 2, or 3 doses of the vaccine at different ages and time points, as well as geographic variations in uptake. Only doses received before 12 months of age were considered for this analysis. Results: More than 96% of children captured by the database received the first dose of PCV13. Uptake of the second dose ranged from 69% to 90% across the five regions, and 44% to 76% of children received the third (booster) dose within 3 months of the recommended date. Conclusions: These data provide early evidence that the primary doses of PCV13 are being administered at a high level in rural India; however, there is considerable variability between regions. Additionally, the receipt of the booster dose may be lower than desired. Given the importance of the booster dose in reducing pneumococcal transmission, its delivery is essential to ensure maximal benefit of the vaccine program.